Ionis Pharmaceuticals (IONS) Change in Inventory (2013 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Change in Inventory of $25.0 million for Q2 2026, up 85.26% year-over-year from $13.5 million in Q2 2025, and up 7485.8% quarter-over-quarter from -$338000.0 in Q1 2026.
Analysis
Ionis Pharmaceuticals (IONS) Change in Inventory (2013 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Change in Inventory history runs 14 years deep, the most recent figure standing at $25.0 million for Q2 2026.
- In Q2 2026, Change in Inventory rose 85.26% year-over-year to $25.0 million; the TTM figure through Jun 2026 stood at $25.8 million (up 49.87% YoY), while the FY2025 annual figure was $13.7 million, up 169.65% from the prior year.
- Change in Inventory for Q2 2026 stood at $25.0 million, up from -$338000.0 in the prior quarter.
- The five-year high for Change in Inventory was $25.0 million in Q2 2026, with the low at -$4.2 million in Q2 2022.
- The 5-year median for Change in Inventory is -$87500.0 (2023), against an average of $2.3 million.
- The sharpest annual moves came in 2022 and 2025: Change in Inventory plunged 430.77% in 2022, then surged 1590.72% in 2025.
- Ionis Pharmaceuticals' Change in Inventory stood at -$1.2 million in 2022, then gained by 2.83% to -$1.1 million in 2023, then jumped by 545.58% to $5.0 million in 2024, then slumped by 118.36% to -$926000.0 in 2025, then jumped by 2795.9% to $25.0 million in 2026.
- Business Quant data shows IONS's Change in Inventory at $25.0 million in Q2 2026, -$338000.0 in Q1 2026, and -$926000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Ionis Pharmaceuticals | 9.67 Bn | 7.62 Bn | 265.21 Mn | 24.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.96 Mn |
| Mar 31, 2026 | -338,000.00 |
| Dec 31, 2025 | -926,000.00 |
| Sep 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 13.48 Mn |
| Mar 31, 2025 | -1.01 Mn |
| Dec 31, 2024 | 5.04 Mn |
| Sep 30, 2024 | -271,000.00 |
| Jun 30, 2024 | 797,000.00 |
| Mar 31, 2024 | -499,000.00 |
| Dec 31, 2023 | -1.13 Mn |
| Sep 30, 2023 | 96,000.00 |
| Jun 30, 2023 | 3.34 Mn |
| Mar 31, 2023 | 167,000.00 |
| Dec 31, 2022 | -1.17 Mn |
| Sep 30, 2022 | 834,000.00 |
| Jun 30, 2022 | -4.22 Mn |
| Mar 31, 2022 | -774,000.00 |
| Dec 31, 2021 | 1.88 Mn |
| Sep 30, 2021 | -1.17 Mn |